Pneumonia kills more children under five each year than any other infectious disease – causing over 900,000 deaths each year. With nearly 60% of child pneumonia deaths occurring in countries deemed as “fragile states," the time is now to rejuvenate funding and programmes targeting these geographies.
Nancy Fullman, MPH, is Scientific Advisor at the Institute for Health Metrics and Evaluation (IHME). In this role, she supports the generation, review, and publication of research results across multiple IHME projects. Nancy serves as a central point for implementing the highest possible scientific excellence throughout IHME, as well as advancing IHME’s overall scientific endeavors.
Previously, Nancy spent three years as one of IHME’s first Policy Translation Specialists, leading efforts to translate IHME’s research into actionable, policy-relevant materials and to engage stakeholders around the uses of global health evidence in decision-making. She led policy translation activities for the Access, Bottlenecks, Costs, and Equity (ABCE) project, a multicountry research initiative that assesses drivers of health system performance, and the Malaria Control Policy Assessment (MCPA) project in Zambia and Uganda. As a Policy Translation Specialist, Nancy also produced a pneumonia-focused report and supported work related to the Disease Control Priorities Network (DCPN) study, impact evaluations such as the Gavi Full Country Evaluations (FCE), and subnational benchmarking analyses in Nigeria.
Nancy was a Post-Bachelor Fellow at IHME from 2008 to 2011, during which time she conducted research on malaria interventions and helped launch the MCPA project in Zambia. She received her Master of Public Health in Health Metrics and Evaluation from the University of Washington in 2011. She then spent a year working for the University of California, San Francisco (UCSF) Global Health Group’s Malaria Elimination Initiative, where she led communications and advocacy efforts on behalf of malaria-eliminating countries, before returning to IHME in 2013.
Originally from a small town in New York State, Nancy received her bachelor’s degree in Psychology from Middlebury College.
IHME COVID-19 Forecasting Team, Hay SI. COVID-19 scenarios for the United States. MedRxiv. 12 July 2020. doi:10.1101/2020.07.12.20151191.
Global Burden of Disease Health Financing Collaborator Network. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3. The Lancet. 23 April 2020. doi:10.1016/S0140-6736(20)30608-5.
Hulland EN, Wiens KE, Shirude S, Morgan JD, Bertozzi-Villa A, Farag TH, Fullman N, Kraemer MUG, Miller-Petrie MK, Gupta V, Reiner RC, Rabinowitz P, Wasserheit JN, Bell BP, Hay SI, Weiss DJ, Pigott DM. Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response. BMC Medicine. 30 December 2019. doi:10.1186/s12916-019-1459-6.
GBD 2017 Lower Respiratory Infections Collaborators. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30410-4.
GBD 2017 Diarrhoeal Disease Collaborators. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 30 October 2019. doi:10.1016/S1473-3099(19)30559-6.
Local Burden of Disease 2017 Child Mortality Collaborators. Mapping 123 million neonatal, infant, and child deaths between 2000 and 2017. Nature. 16 October 2019. doi:10.1038/s41586-019-1545-0.
GBD 2017 HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The Lancet HIV. 14 August 2019. doi:10.1016/S2352-3018(19)30196-1.
Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, Cameron E, Twohig KA, Pfeffer DA, Rozier JA, Gibson HS, Rao PC, Casey D, Bertozzi-Villa A, Collins EL, Dalrymple U, Gray N, Harris JR, Howes RE, Kang SY, Keddie Sh, May D, Rumisha S, Thorn MP, Barber R, Fullman N, Hunyh CK, Kulikoff X, Kutz MJ, Lopez AD, Mokdad AH, Naghavi M, Nguyen G, Shackelford KA, Vos T, Wang H, Smith DL, Lim SS, Murray CJL, Bhatt S, Hay SI, Gething PW. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study. The Lancet. 19 June 2019. doi:10.1016/S0140-6736(19)31097-9.
Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, Pfeffer DA, Cameron E, Rao PC, Casey D, Gibson HS, Rozier JA, Dalrymple U, Keddie SH, Collins EL, Harris JR, Guerra CA, Thorn MP, Bisanzio D, Fullman N, Huynh CK, Kulikoff X, Kutz MJ, Lopez AD, Mokdad AH, Naghavi M, Nguyen G, Shackelford KA, Vos T, Wang H, Lim SS, Murray CJL, Price RN, Baird JK, Smith DL, Bhatt S, Weiss DJ, Hay SI, Gething PW. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study. The Lancet. 19 June 2019. doi:10.1016/S0140-6736(19)31096-7
GBD 2017 Child and Adolescent Health Collaborators. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017. JAMA Pediatrics. 29 April 2019. doi:10.1001/jamapediatrics.2019.0337.
Global Burden of Disease Health Financing Collaborator Network. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. The Lancet. 24 April 2019. doi: http://dx.doi.org/10.1016/S0140-6736(19)30841-4
Haakenstad A, Harle AC, Tsakalos G, Micah AE, Tao T, Anjomshoa M, Cohen J, Fullman N, Hay S, Mestrovic T, Mohammed S, Mousavi SM, Nixon MR, Pigott D, Tran K, Murray CJL, Dieleman JL. Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study. The Lancet Infectious Disease. 24 April 2019. doi: http://dx.doi.org/10.1016/S1473-3099(19)30165-3
Mosser JF, Gagne-Maynard W, Rao PC, Osgood-Zimmerman A, Fullman N, Graetz N, Burstein R, Updike RL, Liu PY, Ray SE, Earl L, Deshpande A, Casey DC, Dwyer-Lindgren L, Cromwell EA, Pigott DM, Shearer FM, Larson HJ, Weiss DJ, Bhatt S, Gething PW, Murray CJL, Lim SS, Reiner RC, Hay SI. Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000–2016: a spatial and temporal modelling study. The Lancet. 5 April 2019. doi:10.1016/S0140-6736(19)30226-0.
Moses MW, Pedroza P, Baral R, Bloom S, Brown J, Chapin A, Compton K, Eldrenkamp E, Fullman N, Mumford JE, Nandakumar V, Rosettie K, Sadat N, Shonka T, Flaxman A, Vos T, Murray CJL, Weaver MR. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. The Lancet Public Health. 11 Dec 2018. doi:10.1016/S2468-2667(18)30263-9.
GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1995-2051. doi: http://dx.doi.org/10.1016/S0140-6736(18)32278-5.
GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1684-735. doi: http://dx.doi.org/10.1016/S0140-6736(18)31891-9.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1736-88. doi: http://dx.doi.org/10.1016/S0140-6736(18)32203-7.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1789–858. doi: http://dx.doi.org/10.1016/S0140-6736(18)32279-7.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1859–922. doi: http://dx.doi.org/10.1016/S0140-6736(18)32335-3.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018;392:1923-94. doi: http://dx.doi.org/10.1016/S0140-6736(18)32225-6.
GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 8 Nov 2018; 392:2091–138. doi: http://dx.doi.org/10.1016/S0140-6736(18)32281-5.
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan C, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel D, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Fullman N, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike R, York H, Lopez A, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories using data from the Global Burden of Disease Study 2016. The Lancet. 16 October 2018. doi:10.1016/S0140-6736(18)31694-5.
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30407-9.
GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases. 19 September 2018. doi:10.1016/S1473-3099(18)30424-9.
GBD 2016 Injury Collaborators. Global Mortality From Firearms, 1990-2016. JAMA. 28 Aug 2018; 320(8):792-814. doi:10.1001/jama.2018.10060.
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 23 Aug 2018. doi:10.1016/S0140-6736(18)31310-2
GBD 2016 Greece Collaborators. The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016. The Lancet Public Health. 25 July 2018. doi:10.1016/S2468-2667(18)30130-0.
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 23 May 2018.
Global Burden of Disease Health Financing Collaborator Network. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40. The Lancet. 17 Apr 2018.
US Burden of Disease Collaborators. The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. JAMA. 10 April 2018; 319(14):1-33. doi:10.1001/jama.2018.0158
Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, Graetz N, Kinyoki DK, Ray SE, Bhatt S, Browne AJ, Burstein R, Cameron E, Casey DC, Deshpande A, Fullman N, Gething PW, Gibson HS, Henry NJ, Herrero M, Krause LK, Letourneau ID, Levine AJ, Liu PY, Longbottom J, Mayala BK, Mosser JF, Noor AM, Pigott DM, Piwoz EG, Rao P, Rawat R, Reiner RC, Smith DL, Weiss DJ, Wiens KE, Mokdad AH, Lim SS, Murray CJL, Kassebaum NJ, Hay SI. Mapping child growth failure in Africa between 2000 and 2015. Nature. 28 Feb 2018. doi:10.1038/nature25760
Graetz N, Friedman J, Osgood-Zimmerman A, Burstein R, Biehl MH, Shields C, Mosser JF, Casey DC, Deshpande A, Earl L, Reiner RC, Ray SE, Fullman N, Levine AJ, Stubbs RW, Mayala BK, Longbottom J, Browne AJ, Bhatt S, Weiss DJ, Gething PW, Mokdad AH, Lim SS, Murray CJLM, Gakidou E, Hay SI. Mapping local variation in educational attainment across Africa. Nature. 28 Feb 2018. doi:10.1038/nature25761
Pigott DM, Deshpande A, Letourneau I, Morozoff C, Reiner Jr RC, Kraemer MUG, Brent SE, Bogoch II, Khan K, Biehl MH, Burstein R, Earl L, Fullman N, Messina JP, Mylne AQN, Moyes CL, Shearer FM, Bhatt S, Brady OJ, Gething PW, Weiss DJ, Tatem AJ, Caley L, De Groeve T, Vernaccini L, Golding N, Horby P, Kuhn JH, Laney SJ, Ng E, Piot P, Sankoh O, Murray CJL, Hay SI. Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis. The Lancet. 11 Oct 2017.
Golding N, Burstein R, Longbottom J, Browne AJ, Fullman N, Osgood-Zimmerman A, Earl L, Bhatt S, Cameron E, Casey DC, Dwyer-Lindgren L, Farag TH, Flaxman AD, Fraser MS, Gething PW, Gibson HS, Graetz N, Krause LK, Kulikoff XR, Lim SS, Mappin B, Morozoff C, Reiner RC Jr, Sliger A, Smith DL, Wang H, Weiss DJ, Murray CJL, Moyes CL, Hay SI. Mapping under-5 and neonatal mortality in Africa, 2000–15: a baseline analysis for the Sustainable Development Goals. The Lancet
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1151–210.
GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1260-344.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390; 1211–59.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1345-1422.
GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1084–1150.
GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 12 Sept 2017: 390; 1423–59.
GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases. 23 Aug 2017. doi: http://dx.doi.org/10.1016/S1473-3099(17)30396-1
Wollum A, Dansereau E, Fullman N, Achan J, Bannon KA, Burstein R, Conner RO, DeCenso B, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Masters SH, Njuguna P, Okiro EA, Odeny TA, Roberts DA, Gakidou E, Duber HC. The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda. BMC Health Services Research. 2017 Aug 16. doi: 10.1186/s12913-017-2512-9.
GBD Diarrheal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrheal diseases: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases. 2017 Jun 1. http://dx.doi.org/10.1016/PII
GBD 2015 Healthcare Access and Quality Collaborators. Healthcare Access and Quality Index based on mortality from causes amenable to personal healthcare in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease 2015 study. The Lancet. 2017 May 18.
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017 April 7;14:48. http://dx.doi.org/10.1016/S0140-6736(17)30819-X
The Global Burden of Disease Child and Adolescent Health Collaboration. Child and adolescent health from 1990 to 2015: Findings from the Global Burden of Disease, Injuries, and Risk Factors 2015 Study. JAMA Pediatrics. 2017;171(6):1-21. doi:10.1001/jamapediatrics.2017.0250.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1659–1724.
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1603–1658.
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1775–1812.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1459–1544.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1545–1602.
GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016 Oct 7; 388:1725–1774.
Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, Correa-Rotter R, Rivera JA, Barquera S, González-Pier E, Aburto-Soto T*, Amorin de Castro EF*, Barrientos-Gutiérrez T*, Basto-Abreu AC*, Batis C*, Borges G*, Campos-Nonato I*, Campuzano-Rincón JC*, Cantoral-Preciado AJ*, Contreras-Manzano AG*, Cuevas-Nasu L*, Cruz-Gongora VV*, Diaz-Ortega JL*, García-García ML*, Garcia-Guerra A*, González de Cossío T*, González-Castell LD*, Heredia-Pi I*, Hijar-Medina MC*, Jauregui A*, Jimenez-Corona A*, Lopez-Olmedo N*, Magis-Rodríguez C*, Medina-Garcia C*, Medina-Mora ME*, Mejia-Rodriguez F*, Montañez JC*, Montero P*, Montoya A*, Moreno-Banda GL*, Pedroza-Tobías A*, Pérez-Padilla R*, Quezada AD*, Richardson-López-Collada VL*, Riojas-Rodríguez H*, Ríos Blancas MJ*, Razo-Garcia C*, Romero Mendoza MP*, Sánchez-Pimienta TG*, Sánchez-Romero LM*, Schilmann A*, Servan-Mori E*, Shamah-Levy T*, Téllez-Rojo MM*, Texcalac-Sangrador JL*, Wang H, Vos T, Forouzanfar MH, Naghavi M, Lopez AD, Murray CJL, Lozano R†. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2016 5 October.
Lim SS, Allen K, Bhutta ZA, Dandona L, Forouzanfar MH, Fullman N, Gething PW, Goldberg EM, Hay SI, Holmberg M, Kinfu Y, Kutz MJ, Larson HJ, Liang X, Lopez AD, Lozano R, McNellan CR, Mokdad AH, Mooney MD, Naghavi M, Olsen HE, Pigott DM, Salomon JA, Vos T, Wang H, Abajobir AA*, Abate KH*, Abbafati C*, Abbas KM*, Abd-Allah F*, Abdulle AM*, Abraham B*, Abubakar I*, Abu-Raddad LJ*, Abu-Rmeileh NME*, Abyu GY*, Achoki T*, Adebiyi AO*, Adedeji IA*, Afanvi KA*, Afshin A*, Agarwal A*, Agrawal A*, Ahmad Kiadaliri A*, Ahmadieh H*, Ahmed KY*, Akanda AS*, Akinyemi RO*, Akinyemiju TF*, Akseer N*, Al-Aly Z*, Alam K*, Alam U*, Alasfoor D*, AlBuhairan FS*, Aldhahri SF*, Aldridge RW*, Alemu ZA*, Ali R*, Alkerwi A*, Alkhateeb MAB*, Alla F*, Allebeck P*, Allen C*, Al-Raddadi R*, Altirkawi KA*, Alvarez Martin E*, Alvis-Guzman N*, Amare AT*, Amberbir A*, Amegah AK*, Amini H*, Ammar W*, Amrock SM*, Andersen HH*, Anderson BO*, Anderson GM*, Antonio CAT*, Anwari P*, Ärnlöv J*, Artaman A*, Asayesh H*, Asghar RJ*, Atique S*, Avokpaho EFGA*, Awasthi A*, Ayala Quintanilla BP*, Azzopardi P*, Bacha U*, Badawi A*, Balakrishnan K*, Banerjee A*, Barac A*, Barber R*, Barker-Collo SL*, Bärnighausen T*, Barrero LH*, Barrientos-Gutierrez T*, Basu S*, Bayou TA*, Bazargan-Hejazi S*, Beardsley J*, Bedi N*, Beghi E*, Béjot Y*, Bell ML*, Bello AK*, Bennett DA*, Bensenor IM*, Benzian H*, Berhane A*, Bernabé E*, Bernal OA*, Betsu BD*, Beyene AS*, Bhala N*, Bhatt S*, Biadgilign S*, Bienhoff KA*, Bikbov B*, Binagwaho A*, Bisanzio D*, Bjertness E*, Blore J*, Bourne RRA*, Brainin M*, Brauer M*, Brazinova A*, Breitborde NJK*, Broday DM*, Brugha TS*, Buchbinder R*, Butt ZA*, Cahill LE*, Campos-Nonato IR*, Campuzano JC*, Carabin H*, Cárdenas R*, Carrero JJ*, Carter A*, Casey D*, Caso V*, Castañeda-Orjuela CA*, Castillo Rivas J*, Catalá-López F*, Cavalleri F*, Cecílio P*, Chang H*, Chang J*, Charlson FJ*, Che X*, Chen AZ*, Chiang PP*, Chibalabala M*, Chisumpa VH*, Jasmine Choi JJ*, Chowdhury R*, Christensen H*, Ciobanu LG*, Cirillo M*, Coates MM*, Coggeshall M*, Cohen AJ*, Cooke GS*, Cooper C*, Cooper LT*, Cowie BC*, Crump JA*, Damtew SA*, Dandona R*, Dargan PI*, das Neves J*, Davis AC*, Davletov K*, de Castro EF*, De Leo D*, Degenhardt L*, Del Gobbo LC*, Deribe K*, Derrett S*, Des Jarlais DC*, Deshpande A*, deVeber GA*, Dey S*, Dharmaratne SD*, Dhillon PK*, Ding EL*, Dorsey ER*, Doyle KE*, Driscoll TR*, Duan L*, Dubey M*, Duncan BB*, Ebrahimi H*, Endries AY*, Ermakov SP*, Erskine HE*, Eshrati B*, Esteghamati A*, Fahimi S*, Farid TA*, Farinha CSS*, Faro A*, Farvid MS*, Farzadfar F*, Feigin VL*, Felicio MM*, Fereshtehnejad S*, Fernandes JG*, Fernandes JC*, Ferrari AJ*, Fischer F*, Fitchett JRA*, Fitzmaurice C*, Foigt N*, Foreman K*, Fowkes FGR*, Franca EB*, Franklin RC*, Fraser M*, Friedman J*, Frostad J*, Fürst T*, Gabbe B*, Garcia-Basteiro AL*, Gebre T*, Gebrehiwot TT*, Gebremedhin AT*, Gebru AA*, Gessner BD*, Gillum RF*, Ginawi IAM*, Giref AZ*, Giroud M*, Gishu MD*, Godwin W*, Gona P*, Goodridge A*, Gopalani SV*, Gotay CC*, Goto A*, Gouda HN*, Graetz N*, Greenwell KF*, Griswold M*, Guo Y*, Gupta R*, Gupta R*, Gupta V*, Gutiérrez RA*, Gyawali B*, Haagsma JA*, Haakenstad A*, Hafezi-Nejad N*, Haile D*, Hailu GB*, Halasa YA*, Hamadeh RR*, Hamidi S*, Hammami M*, Hankey GJ*, Harb HL*, Haro JM*, Hassanvand MS*, Havmoeller R*, Heredia-Pi* IB, Hoek HW*, Horino M*, Horita N*, Hosgood HD*, Hoy DG*, Htet AS*, Hu G*, Huang H*, Iburg KM*, Idrisov BT*, Inoue M*, Islami F*, Jacobs TA*, Jacobsen KH*, Jahanmehr M*, Jakovljevic MB*, James P*, Jansen HAFM*, Javanbakht M*, Jayatilleke AU*, Jee SH*, Jeemon P*, Jha V*, Jiang Y*, Jibat T*, Jin Y*, Jonas JB*, Kabir Z*, Kalkonde Y*, Kamal R*, Kan H*, Kandel A*, Karch A*, Karema CK*, Karimkhani C*, Karunapema P*, Kasaeian A*, Kassebaum NJ*, Kaul A*, Kawakami N*, Kayibanda JF*, Keiyoro PN*, Kemmer L*, Kemp AH*, Kengne AP*, Keren A*, Kesavachandran CN*, Khader YS*, Khan AR*, Khan EA*, Khan G*, Khang YH*, Khoja TAM*, Khosravi A*, Khubchandani J*, Kieling C*, Kim C*, Kim D*, Kim S*, Kim YJ*, Kimokoti RW*, Kissoon N*, Kivipelto M*, Knibbs LD*, Kokubo Y*, Kolte D*, Kosen S*, Kotsakis GA*, Koul PA*, Koyanagi A*, Kravchenko M*, Krueger H*, Kuate Defo B*, Kuchenbecker RS*, Kuipers EJ*, Kulikoff XR*, Kulkarni VS*, Kumar GA*, Kwan GF*, Kyu HH*, Lal A*, Lal DK*, Lalloo R*, Lam H*, Lan Q*, Langan SM*, Larsson A*, Laryea DO*, Latif AA*, Leasher JL*, Leigh J*, Leinsalu M*, Leung J*, Leung R*, Levi M*, Li Y*, Li Y*, Lind M*, Linn S*, Lipshultz SE*, Liu PY*, Liu S*, Liu Y*, Lloyd BK*, Lo L*, Logroscino G*, Lotufo PA*, Lucas RM*, Lunevicius R*, Magdy Abd El Razek M*, Magis-Rodriguez C*, Mahdavi M*, Majdan M*, Majeed A*, Malekzadeh R*, Malta DC*, Mapoma CC*, Margolis DJ*, Martin RV*, Martinez-Raga J*, Masiye F*, Mason-Jones AJ*, Massano J*, Matzopoulos R*, Mayosi BM*, McGrath JJ*, McKee M*, Meaney PA*, Mehari A*, Mekonnen AB*, Melaku YA*, Memiah P*, Memish ZA*, Mendoza W*, Mensink GBM*, Meretoja A*, Meretoja TJ*, Mesfin YM*, Mhimbira FA*, Micha R*, Miller TR*, Mills EJ*, Mirarefin M*, Misganaw A*, Mitchell PB*, Mock CN*, Mohammadi A*, Mohammed S*, Monasta L*, Monis JD*, Montañez Hernandez JC*, Montico M*, Moradi-Lakeh M*, Morawska L*, Mori R*, Mueller UO*, Murdoch ME*, Murimira B*, Murray J*, Murthy GVS*, Murthy S*, Musa KI*, Nachega JB*, Nagel G*, Naidoo KS*, Naldi L*, Nangia V*, Neal B*, Nejjari C*, Newton CR*, Newton JN*, Ngalesoni FN*, Nguhiu P*, Nguyen G*, Nguyen QL*, Nisar MI*, Nkamedjie Pete PM*, Nolte S*, Nomura M*, Norheim OF*, Norrving B*, Obermeyer CM*, Ogbo FA*, Oh I*, Oladimeji O*, Olivares PR*, Olusanya BO*, Olusanya JO*, Opio JN*, Oren E*, Ortiz A*, Osborne RH*, Ota E*, Owolabi MO*, Mahesh PA*, Park E*, Park H*, Parry CD*, Parsaeian M*, Patel T*, Patel V*, Paternina Caicedo AJ*, Patil ST*, Patten SB*, Patton GC*, Paudel D*, Pedro JM*, Pereira DM*, Perico N*, Pesudovs K*, Petzold M*, Phillips MR*, Piel FB*, Pillay JD*, Pinho C*, Pishgar F*, Polinder S*, Poulton RG*, Pourmalek F*, Qorbani M*, Rabiee RHS*, Radfar A*, Rahimi-Movaghar V*, Rahman M*, Ur Rahman MH*, Ur Rahman S*, Rai RK*, Rajsic S*, Raju M*, Ram U*, Rana SM*, Ranabhat CL*, Ranganathan K*, Rao PC*, Refaat AH*, Reitsma MB*, Remuzzi G*, Resnikoff S*, Ribeiro AL*, Rios Blancas MJ*, Roba HS*, Roberts B*, Rodriguez A*, Rojas-Rueda D*, Ronfani L*, Roshandel G*, Roth GA*, Rothenbacher D*, Roy A*, Roy N*, Sackey BB*, Sagar R*, Saleh MM*, Sanabria JR*, Santomauro DF*, Santos IS*, Sarmiento-Suarez R*, Sartorius B*, Satpathy M*, Savic M*, Sawhney M*, Sawyer SM*, Schmidhuber J*, Schmidt MI*, Schneider IJC*, Schutte AE*, Schwebel DC*, Seedat S*, Sepanlou SG*, Servan-Mori EE*, Shackelford K*, Shaheen A*, Shaikh MA*, Shamah Levy T*, Sharma R*, She J*, Sheikhbahaei S*, Shen J*, Sheth KN*, Shey M*, Shi P*, Shibuya K*, Shigematsu M*, Shin M*, Shiri R*, Shishani K*, Shiue I*, Sigfusdottir ID*, Silpakit N*, Silva DAS*, Silverberg JI*, Simard EP*, Sindi S*, Singh A*, Singh GM*, Singh JA*, Singh OP*, Singh PK*, Skirbekk V*, Sligar A*, Soneji S*, Søreide K*, Sorensen RJD*, Soriano JB*, Soshnikov S*, Sposato LA*, Sreeramareddy CT*, Stahl H*, Stanaway JD*, Stathopoulou V*, Steckling N*, Steel N*, Stein DJ*, Steiner C*, Stöckl H*, Stranges S*, Strong M*, Sun J*, Sunguya BF*, Sur P*, Swaminathan S*, Sykes BL*, Szoeke CEI*, Tabarés-Seisdedos R*, Tabb KM*, Talongwa RT*, Tarawneh MR*, Tavakkoli M*, Taye B*, Taylor HR*, Tedla BA*, Tefera W*, Tegegne TK*, Tekle DY*, Shifa GT*, Terkawi AS*, Tessema GA*, Thakur JS*, Thomson AJ*, Thorne-Lyman AL*, Thrift AG*, Thurston GD*, Tillmann T*, Tobe-Gai R*, Tonelli M*, Topor-Madry R*, Topouzis F*, Tran BX*, Tsala Dimbuene Z*, Tura AK*, Tuzcu EM*, Tyrovolas S*, Ukwaja KN*, Undurraga EA*, Uneke CJ*, Uthman OA*, van Donkelaar A*, Varakin YY*, Vasankari T*, Vasconcelos AMN*, Veerman JL*, Venketasubramanian N*, Verma RK*, Violante FS*, Vlassov VV*, Volkow P*, Vollset SE*, Wagner GR*, Wallin MT*, Wang L*, Wanga V*, Watkins DA*, Weichenthal S*, Weiderpass E*, Weintraub RG*, Weiss DJ*, Werdecker A*, Westerman R*, Whiteford HA*, Wilkinson JD*, Wiysonge CS*, Wolfe CDA*, Wolfe I*, Won S*, Woolf AD*, Workie SB*, Wubshet M*, Xu G*, Yadav AK*, Yakob B*, Yalew AZ*, Yan LL*, Yano Y*, Yaseri M*, Ye P*, Yip P*, Yonemoto N*, Yoon S*, Younis MZ*, Yu C*, Zaidi Z*, Zaki MES*, Zambrana-Torrelio C*, Zapata T*, Zegeye EA*, Zhao Y*, Zhou M*, Zodpey S*, Zonies D*, Murray CJL†. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet. 2016 Sep 21. doi: 10.1016/S0140-6736(16)31467-2.
*Authors listed alphabetically
Di Giorgio L, Moses MW, Fullman N, Wollum A, Conner RO, Achan J, Achoki T, Bannon KA, Burstein R, Dansereau E, DeCenso B, Delwiche K, Duber HC, Gakidou E, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Maboshe M, Masiye F, Masters SH, Mphuka C, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Murray CJL, Flaxman AD. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-
Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM, Mooney MD, Fraser MS, Sligar A, Salomon J, Larson HJ, Friedman J, Abajobir AA, Abate KA, Abbas KM, Abd El Razek MM, Abd-Allah F, Abdulle AM, Abera SF, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NME, Abyu GY, Adebiyi AO, Adedeji IA, Adelekan AL, Adofo K, Adou AK, Ajala ON, Akinyemiju TF, Akseer N, Al Lami FH, Al-Aly Z, Alam K, Alam NKM, Alasfoor D, Aldhahri SFS, Aldridge RW, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Ali R, Alkerwi A, Alla F, Mohammad R, Salem Al-Raddadi S, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Amberbir A, Amegah AK, Ammar W, Amrock SM, Antonio CAT, Anwari P, Ärnlöv J, Artaman A, Asayesh H, Asghar RJ, Assadi R, Atique S, Atkins LS, Avokpaho EFGA, Awasthi A, Ayala Quintanilla BP, Bacha U, Badawi A, Barac A, Bärnighausen T, Basu A, Bayou TA, Bayou YT, Bazargan-Hejazi S, Beardsley J, Bedi N, Bennett DA, Bensenor IM, Betsu BD, Addisu Shunu Beyene AS, Bhatia E, Bhutta ZA, Biadgilign S, Bikbov B, Birlik SM, Bisanzio D, Brainin M, Brazinova A, Breitborde NJK, Brown A, Burch M, Butt ZA, Campuzano JC, Cárdenas R, Carrero JJ, Castañeda-Orjuela CA, Castillo Rivas J, Catalá-López F, Chang H, Chang J, Chavan L, Chen W, Chiang PP, Chibalabala M, Chisumpa VH, Choi JJ, Jesudas Christopher D, Ciobanu LG, Cooper C, Dahiru T, Damtew SA, Dandona L, Dandona R, das Neves J, de Jager P, De Leo D, Degenhardt L, Dellavalle RP, Deribe K, Deribew A, Des Jarlais DC, Dharmaratne SD, Ding EL, Doshi PP, Driscoll TR, Dubey M, Elshrek YM, Elyazar I, Endries AY, Ermakov SP, Eshrati B, Esteghamati A, Faghmous IDA, Farinha CS, Faro A, Farvid MS, Farzadfar F, Fereshtehnejad S, Fernandes JC, Fischer F, Fitchett JRA, Foigt N, Fullman N, Fürst T, Gankpé FG, Gebre T, Gebremedhin AT, Gebru AA, Geleijnse JM, Gessner BD, Gething PW, Ghiwot TT, Giroud M, Gishu MD, Glaser E, Goenka S, Goodridge A, Gopalani SV, Goto A, Gugnani HC, Guimaraes MDC, Gupta R, Gupta R, Gupta V, Haagsma J, Hafezi-Nejad N, Hagan H, Hailu GB, Hamadeh RR, Hamidi S, Hammami M, Hankey GJ, Hao Y, Harb HL, Harikrishnan S, Haro JM, Harun KM, Havmoeller R, Hedayati MT, Heredia-Pi IB, Hoek HW, Horino M, Horita N, Hosgood HD, Hoy DG, Hsairi M, Hu G, Huang H, Huang JJ, Iburg KM, Idrisov BT, Innos K, Iyer VJ, Jacobsen KH, Jahanmehr N, Jakovljevic MB, Javanbakht M, Jayatilleke AU, Jeemon P, Jha V, Jiang G, Jiang Y, Jibat T, Jonas JB, Kabir Z, Kamal R, Kan H, Karch A, Karema CK, Karletsos D, Kasaeian A, Anil Kaul, Kawakami N, Kayibanda JF, Keiyoro PN, Kemp AH, Kengne AP, Kesavachandran CN, Khader YS, Khalil I, Khan AR, Ejaz Khan A, Khang Y, Khubchandani J, Kim YJ, Kinfu Y, Kivipelto M, Kokubo Y, Kosen S, Koul PA, Koyanagi A, Kuate Defo B, Kucuk Bicer B, Kulkarni VS, Kumar GA, Kumar Lal D, Lam H, Lam JO, Langan SM, Lansingh VC, Larsson A, Leigh J, Leung R, Li Y, Lim SS, Lipshultz SE, Liu S, Lloyd BK, Logroscino G, Lotufo PA, Lunevicius R, Magdy Abd El Razek H, Mahdavi M, Mahesh PA, Majdan M, Majeed A, Makhlouf C, Malekzadeh R, Mapoma CC, Marcenes W, Martinez-Raga J, Marzan MB, Masiye F, Mason-Jones AJ, Mayosi BM, McKee M, Meaney PA, Mehndiratta MM, Mekonnen AB, Melaku YA, Memiah P, Memish ZA, Mendoza W, Meretoja A, Meretoja TJ, Mhimbira FA, Miller TR, Mikesell J, Mirarefin M, Mohammad KA, Mohammed S, Mokdad AH, Monasta L, Moradi-Lakeh M, Mori R, Mueller UO, Murimira B, Murthy GVS, Naheed A, Naldi L, Nangia V, Nash D, Nawaz H, Nejjari C, Ngalesoni FN, Ngirabega JD, Nguyen QL, Nisar MI, Norheim OF, Norman RE, Nyakarahuka L, Ogbo FA, Oh I, Ojelabi FA, Olusanya BO, Olusanya JO, Opio JN, Oren E, Ota E, Park H, Park J, Patil ST, Patten SB, Paul VK, Pearson K, Peprah EK, Pereira DM, Perico N, Pesudovs K, Petzold M, Phillips MR, Pillay JD, Plass D, Polinder S, Pourmalek F, Prokop DM, Qorbani M, Rafay R, Rahimi K, Rahimi-Movaghar V, Rahman M, Rahman MH, Rahman S, Rai RK, Rajsic S, Ram U, Rana SM, Rao PV, Remuzzi G, Rojas-Rueda D, Ronfani L, Roshandel G, Roy A, Ruhago GM, Saeedi MY, Sagar R, Saleh MM, Sanabria JR, Santos IS, Sarmiento-Suarez R, Sartorius B, Sawhney M, Schutte AE, Schwebel DC, Seedat S, Sepanlou SG, Servan-Mori EE, Shaikh MA, Sharma R, She J, Sheikhbahaei S, Shen J, Shibuya K, Shin HH, Sigfusdottir ID, Silpakit N, Silva DAS, Silveira DGA, Simard EP, Sindi S, Singh JA, Singh OP, Singh PK, Skirbekk V, Sliwa K, Soneji S, Sorensen RJD, Soriano JB, Soti DO, Sreeramareddy CT, Stathopoulou V, Steel N, Sunguya BF, Swaminathan S, Sykes BL, Tabarés-Seisdedos R, Talongwa RT, Tavakkoli M, Taye B, Tedla BA, Tekle T, Shifa GT, Temesgen AM, Terkawi AS, Tesfay FH, Tessema GA, Thapa K, Thomson AJ, Thorne-Lyman AL, Tobe-Gai R, Topor-Madry R, Towbin JA, Tran BX, Dimbuene ZT, Tsilimparis N, Tura AK, Ukwaja KN, Uneke CJ, Uthman OA, Venketasubramanian N, Vladimirov SK, Vlassov VV, Vollset SE, Wang L, Weiderpass E, Weintraub RG, Werdecker A, Westerman R, Wijeratne T, Wilkinson JD, Wiysonge CS, Wolfe CDA, Won S, Wong JQ, Xu G, Yadav AK, Yakob B, Yalew AZ, Yano Y, Yaseri M, Yebyo HG, Yip P, Yonemoto N, Yoon S, Younis MZ, Yu C, Yu S, Zaidi Z, Zaki ME, Zeeb H, Zhang H, Zhao Y, Zodpey S, Zoeckler L, Zuhlke LJ, Lopez AD, Murray CJL. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015. The Lancet HIV. 2016 Jul 19. doi: 10.1016/S2352-3018(16)30087-X.
Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou G, Haakenstad A, Levine AJ, Achan J. Evaluating facility-based antiretroviral therapy program effectiveness: a pilot study comparing viral load suppression and retention rates. Tropical Medicine & Hygiene. 2016 March 21. doi: 10.1111/tmi.12694.
Ng M, Colson KE, Fullman N, Dwyer-Lindgren L, Achoki T, Schneider MT, Mulenga P, Hangoma P, Masiye F, Gakidou E. Assessing the contribution of malaria vector control and other maternal and child health interventions in reducing all-cause under-5 mortality in Zambia. American Journal of Tropical Medicine and Hygiene. 2016 Feb 15. doi: 10.4269/ajtmh.15-0315.
Di Giorgio L, Flaxman AD, Moses MW, Fullman N, Hanlon M, Conner RO, Wollum A, Murray CJL. Efficiency of health care production in low-resource settings: a Monte-Carlo simulation to compare the performance of Data Envelopment Analysis, Stochastic Distance Functions, and an ensemble model. PLOS ONE. 2016 Jan 26. doi: 10.1371/journal.pone.0147261.
Roberts DA, Ng M, Ikilezi G, Gasasira G, Dwyer-Lindgren L, Fullman N, Nalugwa T, Kamya M, Gakidou E. Benchmarking health system performance across regions in Uganda: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 1990–2011. BMC Medicine. 2015 December 3;13(285). doi: 10.1186/s12916-015-0518-x.
Wollum A, Burstein R, Fullman N, Dwyer-Lindgren L, Gakidou E. Benchmarking health system performance across states in Nigeria: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 2000–2013. BMC Medicine. 2015 2 September.
Colson KE, Dwyer-Lindgren L, Achoki T, Fullman N, Schneider M, Mulenga P, Hangoma P, Ng M, Masiye F, Gakidou E. Benchmarking health system performance across districts in Zambia: a systematic analysis of levels and trends in key maternal and child health interventions from 1990 to 2010. BMC Medicine. 2015 April 2. doi: 10.1186/s12916-0150308-5.
Ng M, Fullman N, Dieleman JL, Flaxman AD, Murray CJL, Lim SS. Effective coverage: a metric for monitoring universal health coverage. PLoS Medicine. 2014 Sept 22. doi: 10.1371/journal.pmed.1001730.
Fullman N, Flaxman A, Leach-Kemon K, Rajaratnam JK, Lozano R. Measuring the world’s health: How good are our estimates? In: Brown GW, Yamey G, Wamala S, eds. The Handbook of Global Health Policy. John Wiley & Sons, Ltd, 2014: 97–117.
Cotter C, Sturrock HJW, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RGA. The changing epidemiology of malaria elimination: new strategies for new challenges. The Lancet. 2013 Sep; 382(9895).
Fullman N, Burstein R, Lim S, Medlin C, Gakidou E. Nets, spray or both? The effectiveness of insecticide-treated nets and indoor residual spraying in reducing malaria morbidity and child mortality in sub-Saharan Africa. Malaria Journal. 2013; 12:62. doi:1
Gakidou E, Fullman N. Monitoring health inequalities: measurement considerations and implications. University of Queensland: Health Information Systems Knowledge Hub. 2012 Oct; 20. http://www.uq.edu.au/hishub/docs/WP20/HISHUB-20-WP-WEB-22Oct12.pdf.
Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet. 2012; 379:413-431.
Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, Gakidou E. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Medicine. September 2011; 8(9): e1001.
Flaxman AD, Fullman N, Otten MW Jr., Menon M, Cibulskis RE, Ng M, Murray CJL, Lim SS. Rapid scaling-up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: A systematic synthesis of supply, distribution, and household survey data. PLoS Medicine. 2010 August 17; 7(8): e1000328.
February 19, 2016
November 12, 2015
We know what works to fight pneumonia in children. Improving access to prompt diagnosis and treatment of pneumonia and scaling up vaccines that protect children against particularly deadly strains has occurred in many countries. So why has progress against pneumonia fallen behind?
September 3, 2015
July 2015 saw two big milestones for Nigeria’s quest to eliminate polio. First, the country hit the one-year mark of recording zero polio cases, a significant achievement in global health. Second, Nigeria finished introducing the inactivated polio vaccine (IPV) into routine immunization systems in five more states, accelerating the new vaccine’s implementation.
May 18, 2015
Since 2013, SJN has partnered with the Institute for Health Metrics and Evaluation (IHME) to share instances of exceptional progress and success in public health (known as “positive deviants”) using research and data produced at IHME. This weekly series highlights a timely example of positive deviance and shows you what locality has seen the most gains. We don’t, however, always know why such successes took place, which is why we look to journalists like you, in hopes that you’ll use these data as inspiration for stories. Run with the data. Report. Research. Find out how these countries are succeeding–and publish what you find with the world.
May 4, 2015
Educating women saves lives – and the world is getting better at doing both.
April 10, 2015
The benefits of breastfeeding to the health and development of newborn children are well-documented, with ‘exclusive’ breastfeeding in the first six months of life shown to enhance children’s immunity to infectious disease
April 3, 2015
As improving the quality of health services and people’s access to them becomes more of a global priority (especially in the wake of the Ebola crisis), it’s easy to forget that “health” – how we live and die, and how we interact with health systems – rarely happens at the country-level. Global health leaders want to “ensure that every country [have] a robust and resilient health system,” but we also need to look at the wide variations happening within a country to learn from successful, local initiatives.
March 23, 2015
Today is World Tuberculosis Day, a time where international organizations turn a spotlight on the burden of tuberculosis (TB) and heightened action against this deadly disease.
February 13, 2015
With America’s measles outbreak still spreading to new corners of the country, the public’s response is also become increasingly charged. Families are demanding that schools and pediatricians bar unvaccinated children from their premises. Political debates over how or if immunizations should be mandatory have exploded amid the rising measles case count.
January 29, 2015
If you’re a health worker in Uganda, what do you need in order to provide the best possible care for your patients – people who could be suffering from anything from HIV to broken limbs? You need a range of medicines and other medical supplies, like stethoscopes or blood pressure cuffs. And of course enough medical personnel.
January 22, 2015
For the global health field, 2015 is a year with a lot riding on it. The deadline for reaching the Millennium Development Goals (MDGs) looms, and deliberations continue about the post-MDG world should approach sustainable development (and what that should even mean). We’re celebrating improved survival in much of the world, yet we’re still struggling to contain Ebola in West Africa and less traditional “public health” problems, such as violence, are on rise in many places.
December 18, 2014
Literally millions of stories can be found in this new body of results (or explored online with IHME’s data visualization suite). Today, we’re taking a deeper dive into a public health success story where the link between policy efforts and improved health outcomes is only tightening: tobacco control, and in particular, Uruguay’s efforts to take on its tobacco epidemic.
November 20, 2014
There appears to be a disconnect between the global burden of pneumonia and how much money is spent on attempting to reduce this burden, which Humanosphere recently summed up as: Pneumonia leads in killing children, but not in global health financing.
November 13, 2014
What causes more deaths than HIV, malaria, and measles—combined? Bet you didn’t guess pneumonia.
Despite the fact that in 2013, a child died from pneumonia every 35 seconds, minimal funding has gone to addressing this serious public health issue.
November 12, 2014
“We should declare the goal of eradicating malaria because we can eradicate malaria,” Gates said, to some consternation among the malaria experts. He challenged the audience to wipe out malaria for good, as the world did with smallpox in 1980, rather than continuing to simply contain the disease.
November 7, 2014
The rallying cry at this year’s meeting for the American Society of Tropical Medicine & Hygiene (ASTMH), which ended yesterday, was “Accelerating to Zero,” the Gates Foundation’s vision to eradicate malaria. Many places are nearly there: China is closing in on zero malaria and Saudi Arabia is within a few cases of ending malaria for good.
October 29, 2014
Amid the fierce debate and public outcry over American cities quarantining health workers returning from West Africa, at least one difficult question has also emerged: what are the other optimal measures, perhaps more balanced across legal rights and public health needs, we should use against a deadly infectious disease that doesn’t carry a passport?
October 17, 2014
Measles is another infectious disease that can very rapidly upend and ravage any place where people lack exposure or protection against the virus.
September 23, 2014
A 2010 study found that the screening and treatment of infected mothers (thus preventing mother-to-child transmission of syphilis) is “among the most cost-effective public health interventions in existence.”
September 10, 2014
In the US and globally, ALS certainly claims fewer lives each year than more common diseases. Cancer, for example, caused 204 deaths per 100,000 in the US in 2010. At the same time, these more common diseases generally have much better treatment options and longer-term prognoses – and many of them can even be prevented.
September 4, 2014
Since 2009, the Institute for Health Metrics and Evaluation (IHME) has published annual reports tracking development assistance for health (DAH), striving to improve the methods by which we collectively quantify the amount of money that development partners, governments, and other organizations spend to improve health worldwide.
August 25, 2014
Here, we take a deeper dive into Zambia’s health landscape, and how the country has improved its delivery of health interventions.
July 21, 2014
The world has seen tremendous progress in the fight against HIV/AIDS over the last decade, documenting huge advances in treatment effectiveness, access to affordable drugs, and ways to prevent further transmission of the deadly virus.
July 11, 2014
As it turns out, Costa Rica has been scoring big on and off the soccer pitch – especially for child health. Between 1990 and 2010, the small Central American country documented a 48% decline in rates of premature mortality from preterm birth complications and a 53% decrease from neonatal encephalopathy.
April 1, 2014
Nationally, in 1996, 27% of American men were daily smokers (this is also known as prevalence of daily smoking). Sixteen years later, in 2012, prevalence dropped to 22%. Similar progress was found among American women, with rates of daily smoking falling from 22% to 18% between 1996 and 2012.
March 24, 2014
March 24 is World TB Day, and organizers are calling for a “global effort to find, treat, and cure” everyone who has tuberculosis (TB) and to “accelerate progress toward eliminating TB for good.”
March 14, 2014
In Seattle, I often take walking – and getting to my destination safely – for granted. When I’m not bussing somewhere or riding my bike as a means of transport, it’s all on my two feet to get me from A to B. Aside from dodging the occasional cyclist or texting-while-walking offender, I rarely feel as if I’m at-risk of bodily harm.
March 5, 2014
This week I had the opportunity to help launch the results from an impact evaluation assessing district-level trends in intervention coverage and child mortality in Zambia. One of the most striking results – for both IHME researchers and colleagues in Zambia – was the country’s remarkable scale-up of exclusive breastfeeding (EBF), or solely breastfeeding children for the first six months of life.
February 21, 2014
Weibrecht was born in Olympic territory: Lake Placid, New York, home to the winter Olympics in 1932 and 1980. Lake Placid is in Essex County, one of the healthier counties nationwide, with high life expectancy, high rates of physical activity, and relatively low rates of obesity and hypertension. The county is likely helped by an abundance of natural playgrounds and ability to attract athletic types.
February 14, 2014
Several countries documented even greater success in reducing their burdens of rheumatic heart disease. Here we briefly explore two of them and how they may have achieved this progress.
January 28, 2014
The Lancet published a special series on January 20 titled “Health in the Arab World,” which delves into the health successes and challenges found in countries from Algeria to Yemen. Harnessing the research produced through the Global Burden of Disease (GBD) project, IHME documented the region’s disease burdens and health trends from 1990 to 2010 as part of this issue.
December 20, 2013
In global health, 2013 was a big year – especially if you wanted to really dive into data and find stories behind the world’s health successes and challenges.
December 2, 2013
This year’s theme, “Shared Responsibility: Strengthening Results for an AIDS-Free Generation,” reminds us of the event’s original mission in 1988: uniting people, from Argentina to Zimbabwe, to fight the lethal virus and to honor individuals who have died trying.
November 14, 2013
As highlighted by IHME’s recently published report based on the Global Burden of Disease 2010 study, several countries in the European Union (EU) have bucked the global trend and either maintained or recorded declines in rates of health loss from diabetes (as measured by rates of disability-adjusted life years, or DALYs).
November 13, 2013
Yesterday was World Pneumonia Day (#WPD2013 on Twitter), a sobering reminder that the simple disease is the largest killer for children under 5. It killed 1.1 million children in 2012, more than HIV/AIDS and malaria combined.
November 5, 2013
A few weeks ago, we examined declining household air pollution in Peru. In that post, we highlighted the country’s remarkable progress in reducing premature mortality and illness from the risk factor between 1990 and 2010. But what diseases have been most affected?
October 29, 2013
Today is World Stroke Day, a day dedicated to heightening awareness about a condition that afflicts at least one in every six people during their lifetimes. However, this statistic is far from inevitable, as the American Stroke Association emphasizes that stroke is largely preventable, treatable, and beatable.
October 22, 2013
As of 2010, road injuries became the ninth leading cause of death among developing countries, leading to about as many deaths as malaria. In sub-Saharan Africa, 84% more deaths from road injuries occurred in 2010 than 1990.
October 10, 2013
“Moving toward malaria elimination” is the theme of the 6th MIM Pan-African Malaria Conference, which is a meeting of global malaria minds and might in Durban, South Africa happening right now.
September 30, 2013
The Millennium Development Goals, known as MDGs, are comprised of eight overarching anti-poverty targets that were set by global leaders at the UN’s Millennium Summit in 2000. Ranging from gender equality to HIV/AIDS reduction, the MDGs describe explicit goals to achieve by 2015.
September 17, 2013
For many, Peru is known for its stunning mountain landscapes and rich history. The crisp, clean air surrounding the likes of Machu Picchu only heightens the breathtaking sights found at the end of the trek. Unfortunately, this air quality is not found everywhere in Peru, especially in rapidly growing – and increasingly polluted – cities like Lima.
September 4, 2013
One of my favorite things about working at IHME is trying to pinpoint what’s working and what’s not in global health, to identify which places are achieving better health outcomes and where progress may be lagging.
July 16, 2013
On July 10, the Institute for Health Metrics and Evaluation (IHME) published a suite of new papers and data visualizations focused on health trends in the United States, ranging from county-level results on life expectancy to broader, national findings for disease burdens.
July 2, 2013
It only seemed natural to host a population health-based battle of the sexes, using data from the Global Burden of Disease (GBD) 2010 study to determine the winner.
June 28, 2013
Today’s positive deviant comes to us from the Land Down Under! Turns out that in a country associated with beer-drinking bros… there are fewer alcohol-related DALYs among 20 to 24-year old males.
May 21, 2013
Jolie’s humanitarian work as a UN Goodwill Ambassador has brought her to numerous lower-income countries. Largely focused on refugee emergencies and challenges, Jolie has said that her job is to “draw attention to the…human tragedies that you will not find in the headlines.”
May 14, 2013
Today’s positive deviance comes to us from the tiny sub-Saharan African country of Swaziland. Malaria is a top killer in the region, but is on the path of being completely eliminated in Swaziland.